Biosimilars

COVID-19

Cataract Surgery

Cataract

Cataract Therapeutics

Clinical Diagnosis

Cornea

Dry Eye Awareness

Dry Eye

Gene Therapy

Geographic Atrophy

IOL Advances

Imaging

Glaucoma Awareness

Glaucoma Insights

Therapeutic Glaucoma

Interventional Glaucoma

Ocular Allergy

Ocular Surface Disease

Optic Relief

Optometry

Pediatrics

Pharmacy

Indispensable

Practice Management

Presbyopia

Ptosis

Refractive Surgery

Refractive

Retina

Surgery

Technology

Therapeutics

Understanding Antibiotic Resistance

Workplace

News

All News

Contributors

Money Matters

Media

Expert Interviews

Medical World News

Podcasts

Case Based Roundtable Series

Case of the Quarter

EyeView

Grand Rounds

Insights

Rapid Readout

Viewpoints

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Events

Publications

Digital Edition

Europe Ophthalmology Times

Modern Retina

Supplements and Featured Publications

Partners

Subscribe

Resources

Job Board

About

Advertise

Privacy

Editorial

Terms and Conditions

Contact Us

Do Not Sell My Personal Information

Ophthalmology Times - Ophthalmology news, articles, and events

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Glaucoma

View

Examining Real-World Evidence on Latest Therapies for Retinal Disease 

Perspectives on Latest Therapies: Faricimab and Aflibercept 8mg

Videos

Nikolas JS London, MD, FACS presents two cases, one with a 92-year-old woman with a long history of bilateral nAMD, and one with a 70-year-old man with IDDM.

Dr. London examines a case of longstanding bilateral neovascular age-related macular degeneration (AMD), focusing on the patient's clinical history, treatment challenges, and the potential impact of recent therapeutic advancements on management strategies.

A case of longstanding bilateral neovascular AMD

Dr. London discusses the implications of faricimab and aflibercept 8 mg in treating retinal diseases, highlighting their mechanisms, efficacy data, and potential to enhance patient outcomes in conditions like wet age-related macular degeneration.

Dr. London discusses a case of diabetic macular edema (DME) with persistent subretinal fluid, emphasizing the diagnostic considerations, treatment options, and the implications for patient outcomes in the context of evolving therapeutic approaches.

A case of DME with persistent subretinal fluid

Perspectives on Latest Therapies: Faricimab and Aflibercept 8mg

EP: 1.A case of longstanding bilateral neovascular AMD

EP: 2.Perspectives on Latest Therapies: Faricimab and Aflibercept 8mg

EP: 3.A case of DME with persistent subretinal fluid